Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-17-008967
Filing Date
2017-02-09
Accepted
2017-02-09 09:35:49
Documents
2
Period of Report
2017-02-06

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1596
2 EX-24 DOCUMENT attachment1.htm EX-24 4278
  Complete submission text file 0001209191-17-008967.txt   7287
Mailing Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139 617-441-1000
MERRIMACK PHARMACEUTICALS INC (Issuer) CIK: 0001274792 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address MERRIMACK PHARMACEUTICALS, INC. ONE KENDALL SQUARE, SUITE B7201 CAMBRIDGE MA 02139
Business Address
Peters Richard (Reporting) CIK: 0001697628 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35409 | Film No.: 17585021